Barwick TD - Search Results

1

Monitoring Response to Transarterial Chemoembolization in Hepatocellular Carcinoma Using ¹⁸F-Fluorothymidine PET.

Sharma R, Inglese M, Dubash S, Lu H, Pinato DJ, Sanghera C, Patel N, Chung A, Tait PD, Mauri F, Crum WR, Barwick TD, Aboagye EO. Sharma R, et al. Among authors: barwick td. J Nucl Med. 2020 Dec;61(12):1743-1748. doi: 10.2967/jnumed.119.240598. Epub 2020 Jun 8. J Nucl Med. 2020. PMID: 32513905 Free PMC article. Clinical Trial.

2

Respiratory papillomatosis of lung and F-18 FDG PET-CT.

Szyszko T, Gnanasegaran G, Barwick T, Breen R, Cane P, Rankin S. Szyszko T, et al. Clin Nucl Med. 2009 Aug;34(8):521-2. doi: 10.1097/RLU.0b013e3181abb71c. Clin Nucl Med. 2009. PMID: 19617733 No abstract available.

3

Molecular PET and PET/CT imaging of tumour cell proliferation using F-18 fluoro-L-thymidine: a comprehensive evaluation.

Barwick T, Bencherif B, Mountz JM, Avril N. Barwick T, et al. Nucl Med Commun. 2009 Dec;30(12):908-17. doi: 10.1097/MNM.0b013e32832ee93b. Nucl Med Commun. 2009. PMID: 19794320 Review.

4

Multislice SPECT/CT in benign and malignant bone disease: when the ordinary turns into the extraordinary.

Gnanasegaran G, Barwick T, Adamson K, Mohan H, Sharp D, Fogelman I. Gnanasegaran G, et al. Semin Nucl Med. 2009 Nov;39(6):431-42. doi: 10.1053/j.semnuclmed.2009.07.005. Semin Nucl Med. 2009. PMID: 19801222 Review.

5

Occult squamous cell carcinoma of the uvula detected by F-18 FDG PET/CT in a case of carcinoma of unknown primary in the head and neck.

Salem S, Patel NH, Barwick T, Al-Nahhas A, Howard DJ, Zerizer I, Win Z. Salem S, et al. Clin Nucl Med. 2010 Oct;35(10):800-1. doi: 10.1097/RLU.0b013e3181ef09cb. Clin Nucl Med. 2010. PMID: 20838291

6

Use of [11C]choline PET-CT as a noninvasive method for detecting pelvic lymph node status from prostate cancer and relationship with choline kinase expression.

Contractor K, Challapalli A, Barwick T, Winkler M, Hellawell G, Hazell S, Tomasi G, Al-Nahhas A, Mapelli P, Kenny LM, Tadrous P, Coombes RC, Aboagye EO, Mangar S. Contractor K, et al. Clin Cancer Res. 2011 Dec 15;17(24):7673-83. doi: 10.1158/1078-0432.CCR-11-2048. Epub 2011 Oct 28. Clin Cancer Res. 2011. PMID: 22038995

7

The role of early ¹⁸F-FDG PET/CT in prediction of progression-free survival after ⁹⁰Y radioembolization: comparison with RECIST and tumour density criteria.

Zerizer I, Al-Nahhas A, Towey D, Tait P, Ariff B, Wasan H, Hatice G, Habib N, Barwick T. Zerizer I, et al. Eur J Nucl Med Mol Imaging. 2012 Sep;39(9):1391-9. doi: 10.1007/s00259-012-2149-1. Epub 2012 May 30. Eur J Nucl Med Mol Imaging. 2012. PMID: 22644713

8

Role of SPECT/CT in differentiated thyroid cancer.

Barwick TD, Dhawan RT, Lewington V. Barwick TD, et al. Nucl Med Commun. 2012 Aug;33(8):787-98. doi: 10.1097/MNM.0b013e3283550257. Nucl Med Commun. 2012. PMID: 22669053 Review.

9

Thyroid lymphoma incidentally detected by 18F-fluorocholine (FCH) PET/CT.

Eccles A, Challapalli A, Khan S, Barwick T, Mangar S. Eccles A, et al. Clin Nucl Med. 2013 Sep;38(9):755-7. doi: 10.1097/RLU.0b013e31829f59bd. Clin Nucl Med. 2013. PMID: 23856826

10

Exploring the potential of [11C]choline-PET/CT as a novel imaging biomarker for predicting early treatment response in prostate cancer.

Challapalli A, Barwick T, Tomasi G, O' Doherty M, Contractor K, Stewart S, Al-Nahhas A, Behan K, Coombes C, Aboagye EO, Mangar S. Challapalli A, et al. Nucl Med Commun. 2014 Jan;35(1):20-9. doi: 10.1097/MNM.0000000000000014. Nucl Med Commun. 2014. PMID: 24201549

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

92 results

Search Page